During the past decade, Policlinico di Bari conducted 81 clinical trials. In the 10-year time frame, 81 clinical trials started and 26 clinical trials were completed, i.e. on average, 32.1% percent of trials that started reached the finish line to date. In the past 5 years, 43 clinical trials started and 18 clinical trials were completed. i.e. 41.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Policlinico di Bari" #1 sponsor was "Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari" with 13 trials, followed by "Celgene" with 6 trials sponsored, "Eli Lilly and Company" with 5 trials sponsored, "University of Bari" with 5 trials sponsored and "Boehringer Ingelheim" with 5 trials sponsored. Other sponsors include 87 different institutions and companies that sponsored additional 70 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Policlinico di Bari" #1 collaborator was "University of Bari Aldo Moro" with 4 trials as a collaborator, "ARNAS Civico Di Cristina Benfratelli Hospital" with 1 trials as a collaborator, "Associazione Italiana Ematologia Oncologia Pediatrica" with 1 trials as a collaborator, "Azienda Ospedaliera Universitaria Policlinico" with 1 trials as a collaborator and "Bambino Gesù Hospital and Research Institute" with 1 trials as a collaborator. Other collaborators include 38 different institutions and companies that were collaborators in the rest 48 trials.

According to Clinical.Site data, the most researched conditions in "Policlinico di Bari" are "Atrial Fibrillation" (5 trials), "Healthy" (3 trials), "Heart Failure" (3 trials), "Multiple Myeloma" (3 trials) and "Ovarian Cancer" (3 trials). Many other conditions were trialed in "Policlinico di Bari" in a lesser frequency.

Most popular intervention types in "Policlinico di Bari" are "Drug" (69 trials), "Other" (17 trials), "Device" (15 trials), "Procedure" (10 trials) and "Dietary Supplement" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (18 trials), "Dexamethasone" (4 trials), "Lenalidomide" (4 trials), "Tirzepatide" (4 trials) and "Azacitidine" (2 trials). Other intervention names were less common.

The vast majority of trials in "Policlinico di Bari" are 118 trials for "All" genders, 5 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Policlinico di Bari". 1 are not yet recruiting, 22 are recruiting, 17 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 56 completed trials in Policlinico di Bari, undefined suspended trials, and 13 terminated clinical trials to date.

Out of the total trials that were conducted in Policlinico di Bari, 1 "Phase 1" clinical trials were conducted, 17 "Phase 2" clinical trials and 45 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 16 trials that are defined as “Not Applicable".